Transforming growth factor-β2 is associated with atherosclerotic plaque stability and lower risk for cardiovascular events.
Edsfeldt A, Singh P, Matthes F, Tengryd C, Cavalera M, Bengtsson E, Dunér P, Volkov P, Karadimou G, Gisterå A, Orho-Melander M, Nilsson J, Sun J, Gonçalves I.
Edsfeldt A, et al. Among authors: nilsson j.
Cardiovasc Res. 2023 Sep 5;119(11):2061-2073. doi: 10.1093/cvr/cvad079.
Cardiovasc Res. 2023.
PMID: 37200403
Free PMC article.